MB-07811

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameMB-07811
Drug Alias NameVK-2809MB-07811MB-07344
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThyroid hormone receptor beta-1 agonists
TargetsThyroid hormone receptor beta
Therapy Area/IndicationsHypercholesterolemiaHyperlipidemiasMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesPuerto Rico +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLigand Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesViking Therapeutics Inc
Inactive CompaniesLigand Pharmaceuticals Inc
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsHypercholesterolemiaHyperlipidemias

Other Information

ATC CodeN/A
Related LinksN/A